Evidence map›Paper›PMID 32156026›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Fabrication of Hybrid Silver Microstructures from Vermiculite Templates as SERS Substrates.

Nicolas Pazos-Perez, Luca Guerrini, Ramon A Alvarez-Puebla

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nicolas Pazos-PerezDepartment of Physical and Inorganic Chemistry and EMaS, Universitat Rovira I Virgili, Carrer de Marcel∙lí Domingo s/n, Edifici N5, 43007 Tarragona, Spain.ORCID 0000-0002-2326-4231
Luca GuerriniDepartment of Physical and Inorganic Chemistry and EMaS, Universitat Rovira I Virgili, Carrer de Marcel∙lí Domingo s/n, Edifici N5, 43007 Tarragona, Spain.ORCID 0000-0002-2925-1562
Ramon A Alvarez-PueblaDepartment of Physical and Inorganic Chemistry and EMaS, Universitat Rovira I Virgili, Carrer de Marcel∙lí Domingo s/n, Edifici N5, 43007 Tarragona, Spain.
Universitat Rovira i Virgili · ESInstitució Catalana de Recerca i Estudis Avançats · ES

Funding

Generalitat de Cataluña 2017SGR883Ministerio de Economia y Competitividad CTQ2017-88648RMinisterio de Economia y Competitividad RYC-2015-19107Ministerio de Economia y Competitividad RYC-2016-20331Universitat Rovira I Virgili 2018PFR-URV-B2-02
6 · The paper itself

Abstract

There is great interest in developing complex, 3D plasmonic materials with unusual structural properties. This can be achieved via template-assisted approaches exploiting scaffold elements to engineer unique plasmonic substrates, which would be otherwise impossible to synthesize. Herein, we present a novel, simple, and low-cost template-assisted method for producing interconnected 3-D silver microstructures by utilizing vermiculite, a well-known silicate, as both in-situ reductant and template for silver growth. The silicate network of the vermiculite can be easily removed by dissolution with hydrofluoric acid, which, simultaneously, leads to the formation of a magnesium fluoride skeleton supporting a plasmonically active silver film. Optical, morphological, and chemical properties of the materials were extensively investigated, revealing, for example, that hybrid silver microstructures can be exploited as valuable SERS substrates over a broad spectral range of excitation wavelengths.

Indexed as

plasmonicssensingsurface-enhanced Raman scatteringtemplate-assisted synthesisvermiculite

Identifiers

PMID32156026
PMCPMC7153242
OpenAlexW3009205538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.